BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25612765)

  • 1. Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1.
    Vandamme T; Peeters M; Dogan F; Pauwels P; Van Assche E; Beyens M; Mortier G; Vandeweyer G; de Herder W; Van Camp G; Hofland LJ; Op de Beeck K
    J Mol Endocrinol; 2015 Apr; 54(2):137-47. PubMed ID: 25612765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.
    Boora GK; Kanwar R; Kulkarni AA; Pleticha J; Ames M; Schroth G; Beutler AS; Banck MS
    Cancer Genet; 2015; 208(7-8):374-81. PubMed ID: 26087898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.
    Hofving T; Arvidsson Y; Almobarak B; Inge L; Pfragner R; Persson M; Stenman G; Kristiansson E; Johanson V; Nilsson O
    Endocr Relat Cancer; 2018 Mar; 25(3):367-380. PubMed ID: 29444910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1.
    Luley KB; Biedermann SB; Künstner A; Busch H; Franzenburg S; Schrader J; Grabowski P; Wellner UF; Keck T; Brabant G; Schmid SM; Lehnert H; Ungefroren H
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation exome sequencing of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1 reveals different lineages.
    Vandamme T; Beyens M; Peeters M; Van Camp G; de Beeck KO
    Cancer Genet; 2015 Oct; 208(10):523. PubMed ID: 26341699
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array.
    Di Marco M; Astolfi A; Grassi E; Vecchiarelli S; Macchini M; Indio V; Casadei R; Ricci C; D'Ambra M; Taffurelli G; Serra C; Ercolani G; Santini D; D'Errico A; Pinna AD; Minni F; Durante S; Martella LR; Biasco G
    Mol Med Rep; 2015 Nov; 12(5):7479-84. PubMed ID: 26397140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency.
    Wang L; Tsutsumi S; Kawaguchi T; Nagasaki K; Tatsuno K; Yamamoto S; Sang F; Sonoda K; Sugawara M; Saiura A; Hirono S; Yamaue H; Miki Y; Isomura M; Totoki Y; Nagae G; Isagawa T; Ueda H; Murayama-Hosokawa S; Shibata T; Sakamoto H; Kanai Y; Kaneda A; Noda T; Aburatani H
    Genome Res; 2012 Feb; 22(2):208-19. PubMed ID: 22156295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.
    Finnerty BM; Moore MD; Verma A; Aronova A; Huang S; Edwards DP; Chen Z; Seandel M; Scognamiglio T; Du YN; Elemento O; Zarnegar R; Min IM; Fahey TJ
    Endocr Relat Cancer; 2019 Apr; 26(4):411-423. PubMed ID: 30689542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational analysis in cancer exome sequencing.
    Evans P; Kong Y; Krauthammer M
    Methods Mol Biol; 2014; 1176():219-27. PubMed ID: 25030931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
    Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hotspot DAXX, PTCH2 and CYFIP2 mutations in pancreatic neuroendocrine neoplasms.
    Vandamme T; Beyens M; Boons G; Schepers A; Kamp K; Biermann K; Pauwels P; De Herder WW; Hofland LJ; Peeters M; Van Camp G; Op de Beeck K
    Endocr Relat Cancer; 2019 Jan; 26(1):1-12. PubMed ID: 30021865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectral karyotypic and comparative genomic analysis of the endocrine pancreatic tumor cell line BON-1.
    Lopez JR; Claessen SM; Macville MV; Albrechts JC; Skogseid B; Speel EJ
    Neuroendocrinology; 2010; 91(2):131-41. PubMed ID: 19887762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing.
    Patil V; Pal J; Somasundaram K
    Oncotarget; 2015 Dec; 6(41):43452-71. PubMed ID: 26496030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the exome of the LNCaP prostate cancer cell line.
    Spans L; Atak ZK; Van Nieuwerburgh F; Deforce D; Lerut E; Aerts S; Claessens F
    Prostate; 2012 Sep; 72(12):1317-27. PubMed ID: 22213130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole exome sequencing in recurrent early pregnancy loss.
    Qiao Y; Wen J; Tang F; Martell S; Shomer N; Leung PC; Stephenson MD; Rajcan-Separovic E
    Mol Hum Reprod; 2016 May; 22(5):364-72. PubMed ID: 26826164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted exome sequencing and chromosomal microarray for the molecular diagnosis of nevoid basal cell carcinoma syndrome.
    Matsudate Y; Naruto T; Hayashi Y; Minami M; Tohyama M; Yokota K; Yamada D; Imoto I; Kubo Y
    J Dermatol Sci; 2017 Jun; 86(3):206-211. PubMed ID: 28342698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling.
    Ungefroren H; Künstner A; Busch H; Franzenburg S; Luley K; Viol F; Schrader J; Konukiewitz B; Wellner UF; Meyhöfer SM; Keck T; Marquardt JU; Lehnert H
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of paralogous regions in 41,755 exomes uncovers clinically relevant variation.
    Steyaert W; Haer-Wigman L; Pfundt R; Hellebrekers D; Steehouwer M; Hampstead J; de Boer E; Stegmann A; Yntema H; Kamsteeg EJ; Brunner H; Hoischen A; Gilissen C
    Nat Commun; 2023 Oct; 14(1):6845. PubMed ID: 37891200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
    O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
    Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.